Correct Answer: A. Less chances with enucleation than paratidectomy
Frey's syndrome (gustatory sweating) develops due to aberrant regeneration of parasympathetic fibers following parotid surgery. The key discriminator is the relationship between surgical extent and syndrome incidence. Enucleation involves removal of only the tumor with minimal gland manipulation and nerve trauma, whereas paratidectomy (partial or total) requires extensive dissection, greater manipulation of the auriculotemporal nerve, and more tissue trauma. Greater surgical trauma paradoxically leads to MORE aberrant reinnervation, not less. Therefore, enucleation actually has FEWER chances of developing Frey's syndrome compared to paratidectomy—making the statement "less chances with enucleation than paratidectomy" TRUE, not false. The question asks for the statement that is FALSE (the exception). Option A is the correct answer because it is the only TRUE statement being presented as if it were false, or more accurately, it is the statement that does NOT belong in a list of true statements about Frey's syndrome. The pathophysiology involves parasympathetic fibers of the auriculotemporal nerve (a branch of V3) that normally innervate sweat glands in the temporal region. During aberrant regeneration post-parotidectomy, these fibers misdirect and reinnervate sweat glands instead of salivary glands, causing sweating during eating—the hallmark of Frey's syndrome.
Why the other options are wrong
B. Aberrant misdirection of parasympathetic fibers of auriculotemporal nerve — This is the CORE pathophysiology of Frey's syndrome and is absolutely true. The auriculotemporal nerve (V3 branch) carries parasympathetic fibers that normally supply salivary glands; aberrant regeneration causes these fibers to innervate sweat glands instead. This is a fundamental mechanism, not an exception. C. Gustatory sweating — This is the defining clinical feature of Frey's syndrome—sweating over the temporal and cheek region triggered by eating or even thinking about food. It is a well-established symptom and absolutely true. The syndrome is synonymous with gustatory sweating post-parotid surgery. D. Botulinum toxin is one of the treatment suggested — Botulinum toxin (Botox) is an established and widely used treatment for Frey's syndrome in Indian practice, blocking acetylcholine release at the neuroglandular junction and preventing sweating. It is a true statement and represents modern management alongside topical anticholinergics and surgical options.
High-Yield Facts
- Frey's syndrome = gustatory sweating over temporal/cheek region post-parotid surgery due to aberrant parasympathetic reinnervation
- Auriculotemporal nerve (V3 branch) parasympathetic fibers normally supply parotid; aberrant regeneration redirects them to sweat glands
- Enucleation causes FEWER cases of Frey's syndrome than paratidectomy because it involves minimal nerve trauma and gland manipulation
- Botulinum toxin is first-line pharmacological treatment; blocks acetylcholine at neuroglandular junction preventing sweating
- Onset typically 6 months to 2 years post-parotidectomy; incidence increases with extent of surgery and nerve injury
Mnemonics
FREY = Fibers Regenerate Errantly to sweat glands (Y = sweating) Parasympathetic fibers meant for salivary glands misdirect to sweat glands → gustatory sweating. More surgery = more aberrant regeneration. BIG SURGERY = BIG FREY (Botox, Injury, Greater dissection = Greater Frey's) Paratidectomy (big surgery) > enucleation (small surgery) in causing Frey's. Botox is the modern fix.
NBE Trap
NBE pairs "enucleation" with "less chances" to test whether students understand that SMALLER surgical procedures cause FEWER complications from aberrant nerve regeneration—a counterintuitive concept that many confuse by thinking "any parotid surgery = Frey's equally."
Clinical Pearl
In Indian tertiary centers, Frey's syndrome is increasingly recognized post-parotidectomy for benign tumors. Conservative management with topical anticholinergics (glycopyrrolate) is first-line; botulinum toxin injection is reserved for refractory cases and is now widely available in metro centers. Enucleation for small benign tumors is preferred over paratidectomy specifically to reduce this complication.
_Reference: Bailey & Love's Short Practice of Surgery (Parotid gland section); Robbins Pathology (Nerve regeneration); KD Tripathi Pharmacology (Botulinum toxin)_